Brest University, GETBO EA 3878, Brest, F-29609, France.
Brest University, GETBO EA 3878, Brest, F-29609, France; CHU Brest, Hôpital Cavale Blanche, Department of Internal Medicine and Chest Diseases, Brest F-29609, France.
Eur J Intern Med. 2017 Oct;44:39-43. doi: 10.1016/j.ejim.2017.05.029. Epub 2017 Jun 22.
Whether the association between hospitalization and venous thromboembolism (VTE) is modified by the use of thromboprophylaxis in older patients remains insufficiently evaluated. Our objective was to estimate VTE risk associated with hospitalization for acute medical illness depending on prescription of pharmacological thromboprophylaxis, in two different age categories using a 75years cutoff.
Using a case-control design, we estimated the risk for symptomatic VTE associated with hospitalization for acute medical illness depending on prescription of pharmacological thromboprophylaxis in two different age categories using a 75 years cut-off.
750 symptomatic VTE cases and their 750 age and sex-matched controls were analyzed. A total of 145 cases (19.3%) and 91 controls (12.1%) were hospitalized for acute medical illness in the preceding 3months prior to inclusion in the study (p<0.001). Hospitalization for acute medical illness was associated with a 75% increase in VTE risk: OR 1.75 (95% CI: 1.32-2.33). In patients <75years, there was a 2-fold increase in VTE risk associated with hospitalization when thromboprophylaxis was not prescribed: OR 2.01 (95% CI: 1.11-3.62), whereas no association was found when thromboprophylaxis was prescribed: OR 0.93 (95% CI: 0.44-1.95). In patients ≥75years, VTE risk associated with hospitalization remained significant whether or not thromboprophylaxis was prescribed: OR 2.69 (95% CI 1.28-5.66) and OR 2.02 (95% CI: 1.01-4.03) respectively.
Our results suggest that VTE prevention in acutely ill medical patients may be less effective in patients ≥75years. This finding needs to be addressed in further studies.
在老年患者中,住院与静脉血栓栓塞症(VTE)之间的关联是否因使用血栓预防而改变,仍未得到充分评估。我们的目的是使用 75 岁的界限,评估因急性内科疾病住院与处方药理学血栓预防之间的 VTE 风险。
使用病例对照设计,我们根据使用 75 岁界限的两种不同年龄类别中处方的药理学血栓预防,评估因急性内科疾病住院与症状性 VTE 相关的风险。
共分析了 750 例症状性 VTE 病例及其 750 例年龄和性别匹配的对照者。共有 145 例(19.3%)和 91 例(12.1%)对照者在纳入研究前 3 个月内因急性内科疾病住院(p<0.001)。因急性内科疾病住院与 VTE 风险增加 75%相关:OR 1.75(95% CI:1.32-2.33)。在<75 岁的患者中,未处方血栓预防时,住院与 VTE 风险增加 2 倍:OR 2.01(95% CI:1.11-3.62),而处方血栓预防时未发现相关性:OR 0.93(95% CI:0.44-1.95)。在≥75 岁的患者中,无论是否处方血栓预防,与住院相关的 VTE 风险仍然显著:OR 2.69(95% CI 1.28-5.66)和 OR 2.02(95% CI:1.01-4.03)。
我们的结果表明,急性内科疾病患者的 VTE 预防在≥75 岁的患者中可能效果较差。这一发现需要在进一步的研究中解决。